Ireland
--:--IST
Starting soon Observational

Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® Registry

NCT07142902 · tracked via the Priya Life Science Germany tracker
Sponsor
Ovesco Endoscopy AG
Phase
Observational
Started
2025-08
Last updated
2025-08-27

Condition(s) studied

Subepithelial Gastrointestinal TumorsAdenoma

Investigational drug(s) / intervention(s)

Data processing only, treatment is not part of the registry

Data processing only, treatment is not part of the registry: Treatment with the gdFTRD is part of the clinical routine, the registry only comprises data processing after treatment.

Study summary

Endoscopic full-thickness resection (EFTR) is a therapeutic option for the treatment of challenging lesions such as subepithelial tumors (SETs) and epithelial neoplasia extending deeper than the mucosa or associated with significant fibrosis. EFTR may offer a less invasive treatment alternative relative to surgical approaches in selected patients.

The gastroduodenal FTRD System (gdFTRD System) is an instrument for endoscopic full-thickness resection or deep partial wall resection and diagnostic tissue acquisition through removal of suitable lesions in the stomach and duodenum.

The prospectively generated data of the gdFTRD registry shall be used to evaluate the application of the gdFTRD in clinical routine, to verify the acceptability of already known risks and to identify unknown risks and complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria: * All patients of legal age in whom the gdFTRD was used for treatment in the upper GI tract (stomach and duodenum) independently from the registry and * who gave informed consent to data processing Exclusion criteria: * Patients aged under 18 years * Patients in whom the colonic FTRD, diagnostic FTRD or non-device assisted EFTR was used for treatment * Patients who did not give informed consent to data processing

Primary outcome measure(s)

  • Technical success — Directly post-procedure
    Technical success (i.e. target lesion reached and resected; macroscopically complete)

Trial sites (3)

FacilityCityRegionStatus
Universitätsklinikum Freiburg - Klinik für Innere Medizin II Freiburg im Breisgau Germany
RKH Kliniken Ludwigsburg-Bietigheim gGmbH Ludwigsburg Germany
Robert-Bosch-Krankenhaus Stuttgart Germany
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07142902 on ClinicalTrials.gov ↗ ← All trials in Germany